Cargando…
A method of diamorphine (heroin) administration for harm reduction
As societal attitudes toward narcotics have changed, harm reduction strategies have emerged which make it safer to inject intravenous drugs. Diamorphine (heroin) is commonly sold as its free base—better known as brown—which has extremely poor aqueous solubility. As such, it needs to be chemically mo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061844/ https://www.ncbi.nlm.nih.gov/pubmed/36998076 http://dx.doi.org/10.1186/s12954-023-00758-1 |
_version_ | 1785017375450464256 |
---|---|
author | Kavanagh, Oisín N. Machado, Tatiane C. |
author_facet | Kavanagh, Oisín N. Machado, Tatiane C. |
author_sort | Kavanagh, Oisín N. |
collection | PubMed |
description | As societal attitudes toward narcotics have changed, harm reduction strategies have emerged which make it safer to inject intravenous drugs. Diamorphine (heroin) is commonly sold as its free base—better known as brown—which has extremely poor aqueous solubility. As such, it needs to be chemically modified (cooked) to enable administration. Needle exchange programmes commonly supply citric or ascorbic acids which facilitate intravenous administration by increasing heroin solubility. If heroin users mistakenly add too much acid, the low solution pH can cause damage to their veins and, after repeated injury, could result in the loss of that injection site. Currently, advice cards supplied with these exchange kits suggest that the acid should be measured in pinches, which could result in considerable error. This work employs Henderson–Hasselbalch models to analyse the risk of venous damage by placing solution pH within the context of the buffer capacity of the blood. These models also highlight the significant risk of heroin supersaturation and precipitation within the vein, an event that has the potential to cause further harm to the user. This perspective closes with a modified administration method which could be included as part of a wider harm reduction package. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12954-023-00758-1. |
format | Online Article Text |
id | pubmed-10061844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100618442023-03-31 A method of diamorphine (heroin) administration for harm reduction Kavanagh, Oisín N. Machado, Tatiane C. Harm Reduct J Perspective As societal attitudes toward narcotics have changed, harm reduction strategies have emerged which make it safer to inject intravenous drugs. Diamorphine (heroin) is commonly sold as its free base—better known as brown—which has extremely poor aqueous solubility. As such, it needs to be chemically modified (cooked) to enable administration. Needle exchange programmes commonly supply citric or ascorbic acids which facilitate intravenous administration by increasing heroin solubility. If heroin users mistakenly add too much acid, the low solution pH can cause damage to their veins and, after repeated injury, could result in the loss of that injection site. Currently, advice cards supplied with these exchange kits suggest that the acid should be measured in pinches, which could result in considerable error. This work employs Henderson–Hasselbalch models to analyse the risk of venous damage by placing solution pH within the context of the buffer capacity of the blood. These models also highlight the significant risk of heroin supersaturation and precipitation within the vein, an event that has the potential to cause further harm to the user. This perspective closes with a modified administration method which could be included as part of a wider harm reduction package. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12954-023-00758-1. BioMed Central 2023-03-30 /pmc/articles/PMC10061844/ /pubmed/36998076 http://dx.doi.org/10.1186/s12954-023-00758-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Perspective Kavanagh, Oisín N. Machado, Tatiane C. A method of diamorphine (heroin) administration for harm reduction |
title | A method of diamorphine (heroin) administration for harm reduction |
title_full | A method of diamorphine (heroin) administration for harm reduction |
title_fullStr | A method of diamorphine (heroin) administration for harm reduction |
title_full_unstemmed | A method of diamorphine (heroin) administration for harm reduction |
title_short | A method of diamorphine (heroin) administration for harm reduction |
title_sort | method of diamorphine (heroin) administration for harm reduction |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061844/ https://www.ncbi.nlm.nih.gov/pubmed/36998076 http://dx.doi.org/10.1186/s12954-023-00758-1 |
work_keys_str_mv | AT kavanaghoisinn amethodofdiamorphineheroinadministrationforharmreduction AT machadotatianec amethodofdiamorphineheroinadministrationforharmreduction AT kavanaghoisinn methodofdiamorphineheroinadministrationforharmreduction AT machadotatianec methodofdiamorphineheroinadministrationforharmreduction |